Genmab A/S (GNMSF) Net Income - Minority (2018 - 2026)

Genmab A (GNMSF) has 6 years of Net Income - Minority data on file, last reported at -$3.0 million in Q1 2026.

• Quarterly Net Income - Minority rose 13.26% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 million (up 13.26% YoY) and the FY2025 annual result came in at -$3.5 million, up 21.49% from the prior year.
• Net Income - Minority grew to -$3.0 million in Q1 2026, from -$3.4 million in the prior quarter.
• In the past five years, Net Income - Minority ranged from a high of -$2.9 million in Q4 2024 to a low of -$4.4 million in Q1 2024.
• A 3-year average of -$3.4 million and a median of -$3.4 million in 2024 frame the typical range for Net Income - Minority.
• The widest YoY moves for Net Income - Minority: up 21.49% in 2025, down 0.89% in 2025.
• Tracing GNMSF's Net Income - Minority over 3 years: stood at -$2.9 million in 2024, then dropped by 15.12% to -$3.4 million in 2025, then gained by 10.15% to -$3.0 million in 2026.
• The last three Net Income - Minority figures came in at -$3.0 million (Q1 2026), -$3.4 million (Q3 2025), and -$3.5 million (Q1 2025), per Business Quant data.